why choose us

First received: July 30, 2024

Clinical Trial: Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: HER2-negative Metastatic Breast Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of the Efficacy and Safety of Adaptive Therapy for Metastatic Refractory Breast Cancer

Brief Summary: The primary objective of this study is to explore the efficacy and safety of adaptive therapy in the treatment of post-second-line metastatic breast cancer.

Read more